All Articles by Author:

Emily Salmini

Dr. Seungkuk Ahn receives prestigious ERC Starting Grant

[UCD School of Medicine ] The European Research Council has announced the winners of its latest Starting Grant competition. Drs. Seungkuk Ahn and Dr Alan Seltzer, have received a total of almost €4 million in funding to help build their own teams and develop their research.

Heterotypic Tumor Microenvironments Mirror Dynamic Wound-Healing Process

[Trends in Cancer] Scientists synthesize evidence that tumors become locked in either proinflammatory or pro-resolution phases, defined by neutrophil- or macrophage-dominated ecosystems.

Approaches for Recapitulating the Extracellular Matrix in Organs-on-Chip

[Cell Biomaterials] The authors summarize recent advances in recapitulating the ECM in organ-on-chip systems and argue that the next generation of organ-on-chip platforms will be defined not by increasing structural complexity alone but by their ability to integrate biologically instructive ECMs with manufacturable biomaterial systems.

In Vitro and In Vivo Assessment of Biomineralized Amorphous Silica Fiber Scaffolds for Bone Tissue Engineering

[iScience] Researchers developed degradable amorphous silica fiber scaffolds that actively support biomineral nucleation and growth while maintaining long-term stability. The scaffolds degraded linearly over 40 weeks, and biomineralization enhanced compressive modulus by more than 100%.

Extracellular Matrix Remodeling in Tumors: Forces Beyond Fibroblasts

[Cancer Research] Challenging the prevailing fibroblast-centric paradigm, investigators provide an overview of how non-fibroblast cell types engage in dynamic crosstalk and collectively shape the biochemical and biomechanical landscape of tumors.

Extracellular Matrix Alterations and the Antifibrotic Role of Mycophenolate Mofetil in a Model of Peyronie’s Disease

[Journal of Histochemistry & Cytochemistry] Scientists evaluated ECM alterations in a rat model of Peyronie’s disease induced by transforming growth factor beta and to assess the potential antifibrotic effects of mycophenolate mofetil.

Popular

GentiBio Secures NIH Backing for Allogeneic Engineered Treg Therapy in Type 1 Diabetes

[GentiBio, Inc. (AllSci)] GentiBio, Inc. has received a USD 1.07 million NIH Phase II grant from the National Institute of Diabetes and Digestive and Kidney Diseases to advance an allogeneic, off-the-shelf engineered Treg therapy for newly diagnosed type 1 diabetes. q

CD4+CD25+FOXP3+ Regulatory T Cells to Protect against Graft-Versus-Host Disease

[Blood] The authors discuss the history, preclinical studies, and successful translation of CD4+CD25+FoxP3+ Tregs in the context of allogeneic hematopoietic cell transplantation.

UV Irradiation Drives Lineage-Specific MITF-Mediated Transcription of PD-L1 to Confer Immune Tolerance to UV-Mutated Melanocytes

[Immunity] Researchers investigated whether melanocyte-intrinsic transcriptional program(s) underlie immune tolerance to mutations resulting from UV radiation exposure.